1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow KLN-1010: new trials by email Literature Review of KLN-1010 trials Research Report on KLN-1010
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma KLN-1010 - Multiple Myeloma in Relapse, Myeloma Multiple | Phase 1 | Recruiting | Kelonia Therapeutics, Inc. | 70 | 2025-07-16 | 2026-08-28 |
Blood Protein Disorders (1) · Disease (1) · Hematologic Diseases (1) · Hemostatic Disorders (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphoproliferative Disorders (1) · Multiple Myeloma (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Paraproteinemias (1) · Vascular Diseases (1)
Kelonia Therapeutics, Inc. (1)
Australia (1) · United States (1)